Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.83 +2.99 (+4.22%)
At close: Nov 10, 2026 · 4:00 PM EST

Tarsus Pharmaceuticals (TARS) Non Operating Income (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) recorded Non Operating Income of -$1.6 million in Q3 2026, compared with $1.94 million a year earlier.

Analysis

Tarsus Pharmaceuticals (TARS) Non Operating Income (2019 - 2026) Analysis & Trends

On a TTM basis, Tarsus Pharmaceuticals' Non Operating Income came in at $5.64 million as of Sep 30, 2026, down 9.8% year-over-year; for FY2025, it was $6.61 million, up 31.8% from FY2024.

  • Annual Non Operating Income has a five-year compound annual growth rate of 103.8% (FY2020 to FY2025).
  • Across earlier years, Non Operating Income came in at $5.02 million in FY2024 (-31.0%), $7.27 million in FY2023, $617,000 in FY2022 and -$1.62 million in FY2021.
  • The Q3 2026 figure is the lowest quarterly Non Operating Income in data going back to Q3 2019.
  • On a year-over-year basis, Non Operating Income rose in four of the last six quarters, with growth averaging 16.7%.
  • Peak year-over-year performance for Non Operating Income in the last five years was growth of 358.2% in Q3 2023, against a decline of 99.1% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.07 million (Q2 2026), $1.51 million (Q1 2026) and $1.66 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn -1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1.60 Mn
Jun 30, 2026 4.07 Mn
Mar 31, 2026 1.51 Mn
Dec 31, 2025 1.66 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 1.84 Mn
Mar 31, 2025 1.16 Mn
Dec 31, 2024 1.31 Mn
Sep 30, 2024 1.74 Mn
Jun 30, 2024 12,000.00
Mar 31, 2024 1.95 Mn
Dec 31, 2023 2.55 Mn
Sep 30, 2023 1.79 Mn
Jun 30, 2023 1.40 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 1.46 Mn
Sep 30, 2022 390,000.00
Jun 30, 2022 -519,000.00
Mar 31, 2022 -716,000.00
Dec 31, 2021 -349,000.00
API Access

Tarsus Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TARS&period=max&api_key=YOUR_API_KEY